Tag Archives: LOW

Best Medical Stocks To Own For 2019

Investment company Ownership Capital B.V. buys Cognex Corp, Tyler Technologies Inc, Verisk Analytics Inc, MarketAxess Holdings Inc, sells AptarGroup Inc, Visa Inc, Align Technology Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Ownership Capital B.V.. As of 2018-03-31, Ownership Capital B.V. owns 17 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

New Purchases: CGNX, Added Positions: TYL, VRSK, MKTX, CME, Reduced Positions: MA, V, ALGN, HXL, MTD, ANSS, VAR, FRC, PYPL, WAT, Sold Out: ATR,

For the details of Ownership Capital B.V.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Ownership+Capital+B.V.

These are the top 5 holdings of Ownership Capital B.V.Mastercard Inc (MA) – 835,566 shares, 10.63% of the total portfolio. Shares reduced by 18.04%First Republic Bank (FRC) – 1,135,786 shares, 7.64% of the total portfolio. Shares reduced by 2.2%Ansys Inc (ANSS) – 654,540 shares, 7.45% of the total portfolio. Shares reduced by 7.09%Verisk Analytics Inc (VRSK) – 975,296 shares, 7.37% of the total portfolio. Shares added by 22.39%Varian Medical Systems Inc (VAR) – 786,924 shares, 7.01% of the total portfolio. Shares reduced by 2.61%New Purchase: Cognex Corp (CGNX)

Ownership Capital B.V. initiated holding in Cognex Corp. The purchase prices were between $50.77 and $69.62, with an estimated average price of $59.11. The stock is now traded at around $47.17. The impact to a portfolio due to this purchase was 2.64%. The holding were 698,589 shares as of 2018-03-31.

Best Medical Stocks To Own For 2019: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Francesca’s Holdings Corp (NASDAQ:FRAN) – Stock analysts at B. Riley lifted their Q2 2019 earnings per share (EPS) estimates for shares of Francesca’s in a research note issued to investors on Monday, June 18th. B. Riley analyst S. Anderson now anticipates that the specialty retailer will earn $0.08 per share for the quarter, up from their prior estimate of $0.04. B. Riley currently has a “Buy” rating and a $8.00 target price on the stock. B. Riley also issued estimates for Francesca’s’ FY2019 earnings at $0.63 EPS.

  • [By Paul Ausick]

    Francesca’s Holdings Corp. (NASDAQ: FRAN) dropped about 4.5% Monday to post a 52-week low of $5.68 after closing at $5.95 on Friday. The 52-week high is $19.50. Volume was around 2.7 million, more than double the daily average. The specialty retailer lowered its fourth-quarter outlook last Friday and the investor walkaway continues.

  • [By Steve Symington]

    Shares of Francesca’s Holdings (NASDAQ:FRAN) jumped 27.7% in the month of June, according to data from S&P Global Market Intelligence, as investors digested progress shown in the specialty retailer’s latest quarter. To be sure, though shares initially fell after Francesca’s announced fiscal first-quarter results on June 5, 2018, the stock ultimately rebounded to close the day up 8% and continued to rise from there.

  • [By Joseph Griffin]

    Francesca’s Holdings Corp (NASDAQ:FRAN) – Research analysts at B. Riley cut their Q2 2019 earnings estimates for shares of Francesca’s in a note issued to investors on Wednesday, June 6th. B. Riley analyst S. Anderson now anticipates that the specialty retailer will earn $0.04 per share for the quarter, down from their prior estimate of $0.25. B. Riley currently has a “Hold” rating and a $6.00 target price on the stock. B. Riley also issued estimates for Francesca’s’ Q3 2019 earnings at $0.25 EPS and FY2019 earnings at $0.58 EPS.

Best Medical Stocks To Own For 2019: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Chris Lange]

    Lowe’s Companies Inc. (NYSE: LOW) reported its most recent quarterly results before the markets opened on Wednesday. Judging by investors reaction to this report, Lowe’s transformation is going just fine, and analysts seem to agree.

  • [By Chris Lange]

    Lowe’s Companies Inc. (NYSE: LOW) shares saw a nice bounce on Tuesday after the company announced that it would be restructuring its upper level management team. The current CEO, Marvin Ellison, just took over the role on July 2, after receiving the appointment back in May. It seems that he is wasting no time trimming the organization to his liking.

  • [By Jim Crumly]

    As for individual stocks, two retailers surprised observers with the strength of their sales gains. Sales at Lowe’s Companies (NYSE:LOW) rebounded from a cold spring, and Target Corporation (NYSE:TGT) reported a record traffic increase in its stores.

Best Medical Stocks To Own For 2019: CVD Equipment Corporation(CVV)

Advisors’ Opinion:

  • [By Shane Hupp]

    News coverage about CVD Equipment (NASDAQ:CVV) has been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CVD Equipment earned a news impact score of 0.07 on Accern’s scale. Accern also assigned news headlines about the industrial products company an impact score of 47.2607770405573 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    News headlines about CVD Equipment (NASDAQ:CVV) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVD Equipment earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news stories about the industrial products company an impact score of 46.7103888113407 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Best Medical Stocks To Own For 2019: Orion Marine Group Inc(ORN)

Advisors’ Opinion:

  • [By Max Byerly]

    Jacobs Engineering Group (NYSE: JEC) and Orion Group (NYSE:ORN) are both construction companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Orion Group (ORN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Orion Group (ORN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:

    Get Orion Group alerts:

    Analysts Anticipate Orion Group Holdings Inc (ORN) Will Announce Quarterly Sales of $165.45 Million (americanbankingnews.com) Factors Setting the Tone for Dycom (DY) in Q2 Earnings (finance.yahoo.com) Analysts Expect Orion Group Holdings Inc (ORN) Will Announce Earnings of $0.02 Per Share (americanbankingnews.com) Who Are The Major Shareholders Of Orion Investment SA (WSE:ORN)? (finance.yahoo.com) Arnold Van Den Berg Trims Enstar Group, Exits Orion Group (finance.yahoo.com)

    ORN has been the topic of a number of research analyst reports. Zacks Investment Research lowered Orion Group from a “buy” rating to a “hold” rating in a research report on Tuesday, August 7th. ValuEngine upgraded Orion Group from a “sell” rating to a “hold” rating in a report on Saturday, May 26th. Canaccord Genuity restated a “buy” rating and issued a $10.00 price objective on shares of Orion Group in a report on Thursday, August 2nd. Noble Financial set a $10.00 price objective on Orion Group and gave the company a “buy” rating in a report on Friday, August 3rd. Finally, B. Riley raised their price objective on Orion Group from $10.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $10.13.

Best Medical Stocks To Own For 2019: First Capital Bancorp Inc.(VA)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about Virgin America (NASDAQ:VA) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Virgin America earned a news impact score of 0.22 on Accern’s scale. Accern also assigned media coverage about the transportation company an impact score of 45.3779505917989 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Peter Graham]

    A long term performance chart shows JetBlue Airways Corporation giving a good performance that’s still not as good as that of large cap Southwest Airlines Co (NYSE: LUV) while the performance of Alaska Air Group, Inc (NYSE: ALK), which has acquired Virgin America Inc (NASDAQ: VA), seems to have slipped recently:

Top Blue Chip Stocks To Invest In Right Now

Shutterstock

When blue chips get too popular – like the five I’m going to show you today – these “safe stocks” can actually be dangerous to continue holding in your portfolio.

The problem with blue-chip stocks? Call it the “Curse of the Dow.” The Curse says a stock that joins the Dow Jones Industrial Average will essentially hit a wall, underperforming in the ensuing months compared to how it performed before ascension. It’s not perfect, but it’s close – since 1999, 15 of 16 stocks that have joined the Dow have averaged 1% gains over the next six months, but averaged 11% gains in the six months before inclusion.

Why? There are a few factors, but one of the most prevailing is that by the point a stock has joined the Dow, it’s typically nearing the end of its growth ramp and reaching the slower-growth “mature” part of the business cycle.

Top Blue Chip Stocks To Invest In Right Now: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By ]

    Some of those one-time issues were weather events, Teske explained, but the main issue was the Craftsman brand coming to Lowes (LOW) later this year. As that brand moves in, others will be reshuffling, which has led suppliers to lean out their inventories until they figure things out. Briggs already powers a number of Craftsman products, Teske said, so the inventory issues will eventually work themselves out.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Lowes Companies, Inc. (NYSE: LOW) which traded down about 3% at $85.57. The stocks 52-week range is $70.76 to $108.98. Volume was about 7 million compared to the daily average volume of 7.4 million.

  • [By Logan Wallace]

    Van ECK Associates Corp increased its stake in Lowe’s (NYSE:LOW) by 3.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 466,856 shares of the home improvement retailer’s stock after acquiring an additional 14,152 shares during the period. Van ECK Associates Corp owned about 0.06% of Lowe’s worth $40,967,000 as of its most recent SEC filing.

Top Blue Chip Stocks To Invest In Right Now: Legacy Reserves LP(LGCY)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Legacy Reserves LP (NASDAQ:LGCY)’s share price reached a new 52-week high and low on Tuesday . The stock traded as low as $6.49 and last traded at $6.49, with a volume of 508680 shares. The stock had previously closed at $6.25.

  • [By Shane Hupp]

    Legacy Reserves LP (NASDAQ:LGCY) hit a new 52-week high and low on Tuesday . The stock traded as low as $8.74 and last traded at $8.63, with a volume of 42189 shares. The stock had previously closed at $8.36.

  • [By Dan Caplinger]

    The stock market is a market of individual stocks, though, and even with major benchmarks having stalled, some companies are enjoying unparalleled success. In particular, TransEnterix (NYSEMKT:TRXC), BeiGene (NASDAQ:BGNE), and Legacy Resources LP (NASDAQ:LGCY) have all quadrupled in price in just a single year, and investors who are just finding out about them want to know if there are further gains in their futures. There aren’t any sure things in investing, but the prospects that all three of these companies have could fuel additional advances if things go right for them.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Ethan Ryder]

    Shares of Legacy Reserves LP (NASDAQ:LGCY) traded up 2.6% during mid-day trading on Thursday . The company traded as high as $7.45 and last traded at $7.75. 42,406 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 501,679 shares. The stock had previously closed at $7.55.

Top Blue Chip Stocks To Invest In Right Now: Hanwha Q CELLS Co., Ltd. (HQCL)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of Hanwha Q Cells Co (NASDAQ:HQCL) are down more than 4% so far this year — and that’s the good news. Canadian Solaris off 20% while JinkoSolar Holdingis down a whopping 43%. The cost of Chinese solar modules, which make up one-third the cost of a deployed solar power system, are expected to decline 35% this year, then fall another 10% to 15% next year, according to Bloomberg.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Travis Hoium]

    The impact will have ripple effects across the industry. Major manufacturers like Canadian Solar (NASDAQ:CSIQ), JinkoSolar (NYSE:JKS), Hanwha Q Cells (NASDAQ:HQCL), and JA Solar (NASDAQ:JASO) will see margins squeezed as volume and sales prices fall. They were all enjoying higher margins and strong demand in early 2018, so the could reverse to net losses later this year.

Top Blue Chip Stocks To Invest In Right Now: Tyson Foods Inc.(TSN)

Advisors’ Opinion:

  • [By Shane Hupp]

    HL Financial Services LLC purchased a new position in shares of Tyson Foods (NYSE:TSN) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 61,568 shares of the company’s stock, valued at approximately $4,506,000.

  • [By Brian Stoffel]

    Here are the 10 stocks that I think are in the most trouble. Below, I’ll get into how each of them stacks up against these three metrics.

    Company Ticker Main Brands
    Procter & Gamble (NYSE:PG) Tide, Pampers, Old Spice, Gillette
    PepsiCo (NASDAQ:PEP) Pepsi, Tostitos, Aquafina, Quaker Oats
    Coca-Cola (NYSE:KO) Coke, Sprite, Dasani, Minute Maid
    Tyson Foods (NYSE:TSN) Tyson, Jimmy Dean, Hillshire, Sara Lee
    Mondelez (NASDAQ:MDLZ) Oreo, Nabsico, Triscuit, Ritz, Cadbury
    General Mills (NYSE:GIS) Cheerios, Betty Crocker, Pillsbury
    Colgate-Palmolive (NYSE:CL) Colgate, Speedstick, Palmolive, Softsoap
    Kellogg (NYSE:K) Mini-Wheats, Pop-Tarts, Eggos
    Dean Foods (NYSE:DF) Dean, LandOLakes, Organic Valley
    Hain Celestial (NASDAQ:HAIN) Celestial Teas, Arrowhead Mills

    Data source: Company websites.

  • [By Lisa Levin]

    Tyson Foods, Inc. (NYSE: TSN) reported weaker-than-expected results for its fiscal second quarter.

    Tyson posted quarterly earnings of $1.271 per share on sales of $9.773 billion. Analysts expected earnings of $1.32 per share on sales of $9.89 billion. Tyson expects FY18 earnings of $6.55 to $6.70 per share.

  • [By Stephan Byrd]

    Systematic Financial Management LP boosted its position in Tyson Foods, Inc. (NYSE:TSN) by 16.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 115,734 shares of the company’s stock after acquiring an additional 16,022 shares during the quarter. Systematic Financial Management LP’s holdings in Tyson Foods were worth $8,471,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Sanford C. Bernstein started coverage on shares of Tyson Foods (NYSE:TSN) in a research report report published on Thursday, MarketBeat Ratings reports. The brokerage issued an outperform rating on the stock.

Top Blue Chip Stocks To Invest In Right Now: Glacier Bancorp, Inc.(GBCI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News articles about Glacier Bancorp (NASDAQ:GBCI) have been trending somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Glacier Bancorp earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave press coverage about the bank an impact score of 44.9843227025393 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Glacier Bancorp, Inc. (NASDAQ:GBCI)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $41.40 and last traded at $41.05, with a volume of 6787 shares changing hands. The stock had previously closed at $41.15.

  • [By Joseph Griffin]

    Great West Life Assurance Co. Can grew its stake in shares of Glacier Bancorp, Inc. (NASDAQ:GBCI) by 2.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 105,185 shares of the bank’s stock after buying an additional 2,881 shares during the period. Great West Life Assurance Co. Can’s holdings in Glacier Bancorp were worth $4,038,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Swiss National Bank lifted its position in Glacier Bancorp (NASDAQ:GBCI) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,800 shares of the bank’s stock after acquiring an additional 2,900 shares during the period. Swiss National Bank owned about 0.16% of Glacier Bancorp worth $5,212,000 as of its most recent SEC filing.

40,076 Shares in Lowe’s (LOW) Purchased by Mckinley Capital Management LLC Delaware

Mckinley Capital Management LLC Delaware acquired a new stake in Lowe’s (NYSE:LOW) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 40,076 shares of the home improvement retailer’s stock, valued at approximately $3,517,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Almanack Investment Partners LLC. acquired a new stake in shares of Lowe’s in the fourth quarter valued at $106,000. Stonehearth Capital Management LLC acquired a new stake in shares of Lowe’s in the fourth quarter valued at $112,000. Truewealth LLC acquired a new stake in Lowe’s in the fourth quarter valued at $128,000. Cerebellum GP LLC acquired a new stake in Lowe’s in the fourth quarter valued at $129,000. Finally, Harel Insurance Investments & Financial Services Ltd. raised its stake in Lowe’s by 50.0% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,500 shares of the home improvement retailer’s stock valued at $139,000 after buying an additional 500 shares in the last quarter. Institutional investors and hedge funds own 73.53% of the company’s stock.

Get Lowe’s alerts:

NYSE LOW opened at $84.42 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.11 and a debt-to-equity ratio of 2.65. The stock has a market capitalization of $69.93 billion, a PE ratio of 19.19, a P/E/G ratio of 0.89 and a beta of 1.33.

Lowe’s (NYSE:LOW) last released its quarterly earnings results on Wednesday, February 28th. The home improvement retailer reported $0.74 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.87 by ($0.13). Lowe’s had a return on equity of 65.17% and a net margin of 5.02%. The company had revenue of $15.49 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same period in the prior year, the business earned $0.86 EPS. The business’s quarterly revenue was down 1.8% compared to the same quarter last year. analysts expect that Lowe’s will post 5.46 EPS for the current year.

Lowe’s declared that its board has initiated a share buyback program on Friday, January 26th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the home improvement retailer to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 9th. Investors of record on Wednesday, April 25th were issued a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date of this dividend was Tuesday, April 24th. Lowe’s’s dividend payout ratio is currently 37.36%.

A number of research firms have weighed in on LOW. Credit Suisse Group set a $116.00 price target on Lowe’s and gave the company a “buy” rating in a research note on Tuesday, January 16th. JPMorgan Chase restated a “neutral” rating and issued a $100.00 price target on shares of Lowe’s in a research note on Tuesday, March 6th. Gabelli began coverage on Lowe’s in a research note on Wednesday, April 11th. They issued a “buy” rating and a $113.00 price target on the stock. Wedbush restated a “hold” rating and issued a $80.00 price target (down from $85.00) on shares of Lowe’s in a research note on Thursday, March 1st. Finally, Royal Bank of Canada cut their price target on Lowe’s to $102.00 and set an “outperform” rating on the stock in a research note on Thursday, March 1st. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $99.00.

About Lowe’s

Lowe's Companies, Inc, together with its subsidiaries, operates as a home improvement retailer in the United States, Canada, and Mexico. It offers a line of products for maintenance, repair, remodeling, and decorating. The company provides home improvement products in various categories, such as lumber and building materials, tools and hardware, appliances, fashion fixtures, rough plumbing and electrical, seasonal and outdoor living, lawn and garden, paint, millwork, flooring, and kitchens, as well as outdoor power equipment.

Want to see what other hedge funds are holding LOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lowe’s (NYSE:LOW).

Institutional Ownership by Quarter for Lowe`s (NYSE:LOW)

4 Stocks That Could Be Tomorrow's High-Yielders

As a group, dividend hunters tend to have a long-term investment perspective. There’s not much sense investing in a stock just to capture one quarterly payment and then part ways. When we find a strong business generating ample cash and sharing it generously with stockholders, we tend to stick around for a while.

Case in point, I’ve held CME Group (NYSE: CME) in my High-Yield Investing portfolio for almost four years now. When I first took a position in the summer of 2014, the stock offered a regular quarterly dividend of $0.47 per share that added up to a modest yield of 2.6%. Many income investors skipped over it without a second glance.

But I saw a dividend that had already doubled over the previous four years and was poised to rise even further. And this was just the “base salary”. CME also hands out a year-end bonus distribution tied to operating profits earned during the year. With an eye on the future, I added the stock to my portfolio.

Before long, the regular quarterly payout rose to $0.50 per share, then $0.60, then $0.66, and it now stands at $0.70 per share. That’s a healthy increase of nearly 50%. And those hikes attracted plenty of buyers, helping drive the shares from the lower $70’s to a recent close above $164.

If you look up CME on Yahoo Finance today, it shows a rather plain current yield of 1.7%. But counting the latest special dividend, readers who followed my initial recommendation to buy CME four years ago in my High-Yield Investing newsletter are pulling down an annual income stream of 8.5%.

The message here: dividend growth accounts for a large portion of your total returns over time. So if you’re planning to stay on board for a few years (and we often are), then potential distribution increases should be an important consideration when choosing portfolio candidates.

I know some of you may be retirees trying to draw the highest current income stream possible from your nest egg. But others are still in the wealth-accumulation phase and willing to trade a few points of yield today for superior dividend growth tomorrow. If you fall into the latter camp, then today’s stock screen is for you.

Tomorrow’s Best High-Yielders
The stocks in the table below all have an outstanding track record of boosting their payouts at a 10% or faster annual clip. They also have solid earnings growth forecasts to help support future increases.

The stocks in the table above haven’t been fully researched and shouldn’t necessarily be considered portfolio recommendations. They simply meet certain screening criteria.

But as criteria go, these are good ones.

Without looking at anything else, we can reasonably conclude these are financially healthy, shareholder-friendly businesses generating a growing pile of profits.

There were others with robust dividend growth and optimistic outlooks, such as Lowe’s (NYSE: LOW) and Boeing (NYSE: BA), but I didn’t include them in the table because their current yields just don’t measure up.

But stocks like Abbvie (Nasdaq: ABBV) offer the best of both worlds — a current yield that is already double the market average plus an impressive 23% annual dividend growth rate. Since it was spun off from Abbot Labs in 2013, the pharmaceutical company has grown by leaps and bounds, growing top-line revenues by more than $10 billion.

Best-known for its blockbuster arthritis drug Humira, Abbvie rakes in buckets of patent-protected cash flows. Those proceeds are funneled into a fruitful research and development (R&D) program that has a number of promising products in the pipeline for cancer treatment and immunology.

With a payout ratio of 75%, the company has no trouble covering its $3.84 per share annual dividend. And if distributions keep pace with earnings, which are projected to climb 16% annually over the long-haul, stockholders could be raking in $6.00 per share by 2021.

ABBV is a strong candidate that will likely find its way into my portfolio over the next few months.

Want The Best High-Yielders The Market Has To Offer?
The goal of my stock screens is to identify stocks that might be well-suited for my High-Yield Investing portfolio. But like any quantitative tool, this screen should not be used in isolation. You should also evaluate the fundamental characteristics of every potential investment opportunity. In addition, you should assess how well a particular stock or fund matches your investment needs. And do your own due diligence on a security to decide if it is right for your portfolio.

If I find a real gem within these screens, a stock that can actually maintain this level of yield through the years to come, my High-Yield Investing subscribers will be the first to hear about it.

So if you’d like to join us in our search for the best high yields the market has to offer, then I want to invite you to learn more about High-Yield Investing. Like the CME example above, some of our oldest holdings are pulling in “yields on cost” of 10%…13%…and one a nearly unbelievable 20.7%.

You don’t have to settle for the paltry yields offered by most stocks. The high yields are still out there. You just have to know where to look — and my staff and I are here to help you along.

Click here to see how High-Yield Investing can help you pull in 11.2% a year in dividends — and some impressive capital gains to boot.

This article originally appeared on StreetAuthority.com.

better investing

Related USO The Technician's Playbook: Exxon Mobil Revisits Long-Term Support Level Trump Confirms US Exit From Paris Accord: He's Right, It Is A Bad Deal Stock Market Rushes To Record Highs; Did Dow ETF Break Out? (Investor’s Business Daily)
Related KSA These ETFs Could Endure An Oil Slide IHS Markit's Dan Yergin: OPEC Only Reached An 'Agreement To Agree'

The Middle Eastern geopolitical landscape shifted over the weekend after a handful of Gulf countries officially cut ties with the small but rich nation of Qatar.

better investing: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By Elizabeth Balboa]

    Here are the top 10 financial bodies investing in lobbying in 2017:

    American Bankers Association: $5.6 million
    Securities Industry & Financial Market Association: $3.5 million
    Financial Services Roundtable: $3.0 million
    Independent Community Bankers of America: $2.7 million
    Association of International CPAs: $2.6 million
    Citigroup Inc (NYSE: C): $2.5 million
    Investment Company Institute: $2.4 million
    S&P Global Inc (NYSE: SPGI): $2.4 million
    Credit Union National Association: $2.4 million
    HSBC Holdings plc (ADR) (NYSE: HSBC): $2.4 million

    Dozens of others spent more than $1 million, including Ally Financial Inc (NYSE: ALLY), Visa Inc (NYSE: V) and Navient Corp (NASDAQ: NAVI).

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with the financial results from JPMorgan Chase (JPM) and Citigroup (C) .

  • [By Ben Levisohn]

    So we find ourselves in the position we have for most of this year: positive on the market averages but less confident in what stocks to buy. While banks have clearly been the flavor of the day we have generally avoided those names. Both Citigroup (C) and Bank of America (BAC) are only now hitting six year highs and we have never advocated chasing winners. Meanwhile the staid, safe defensive stocks (value) like P&G (PG), Coke (KO), and Philip Morris (PM) are lagging. The dichotomy might be illustrated by retailers where Best Buy has been roaring while Gap Stores has been tanking…

better investing: Nabors Industries Ltd.(NBR)

Advisors’ Opinion:

  • [By Wayne Duggan]

    While Loop maintains a Buy rating on all of the stocks mentioned above, Guggenheim analyst Michael LaMotte isn’t quite so bullish on the sector. Earlier this week, LaMotte downgraded the following oil services stocks from Buy to Neutral:

    Baker Hughes Incorporated (NYSE: BHI)
    Fairmount Santrol Holdings Inc (NYSE: FMSA)
    Helmerich & Payne, Inc. (NYSE: HP)
    Nabors Industries Ltd. (NYSE: NBR)
    Schlumberger Limited. (NYSE: SLB)
    Halliburton
    Superior Energy Services

    Guggenheim also cut its 2017 oil price forecast from $55 to $48/bbl.

  • [By Craig Jones]

    Pete Najarian was watching Nabors Industries Ltd. (NYSE: NBR). He said that the stock has been trading in a range between $8 and $18 over the last 52 weeks and although it spiked 2.82 percent on Wednesday, it's still close to the lower end of the range. Anticipating a move higher, traders were buying the June 11 calls for $0.30. Around 6,000 contracts were bought in the first half of the session. The trade breaks even at $11.30 or 10.78 percent above the current market price. Pete Najarian decided to buy the calls and he is going to hold them for 4-5 weeks.

  • [By Ben Levisohn]

    Last night, Weatherford International (WFT) reported a smaller than expected loss and announcing an alliance with Nabors Industries (NBR)–and the news was celebrated by the market.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Jon Najarian spoke about Nabors Industries Ltd. (NYSE: NBR). He said that somebody bought 6,500 contracts of the July 11 calls for $0.50 in the first half of the session. The trade breaks even at $11.50 or 16.28 percent above the current market price. Jon Najarian has a long position in the name and he is planning to hold it for a month.

  • [By Jon C. Ogg]

    Nabors Industries Ltd. (NYSE: NBR) rose by 22.3% to $16.11 on Wednesday. Its volume of 17.4 million shares was about 2.5 times normal trading volume. Nabors has a consensus analyst price target of $15.04 and a 52-week trading range of $4.93 to $16.50. The company has a total market cap of $4.6 billion.

better investing: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Williams-Sonoma (WSM) reported a mixed third quarter. Comparable-brand sales at Pottery Barn fell, while sales at West Elm continued to outpace its other brands. Home Depot (HD) lifted its full-year earnings estimates after strong sales growth in its third quarter. Lowe’s (LOW) fell short of third-quarter earnings and revenue estimates, while same-store sales growth of 2.7% missed analysts’ 3% target.

  • [By Craig Jones]

    Scott Bauer of Trading Advantage spoke on Bloomberg Markets about a bullish options trade in Lowe's Companies, Inc. (NYSE: LOW).

    He wants to buy the January 85/90 call spread for $1.25. The trade breaks even at $86.25 or 4.70 percent above the current stock price. If the stock jumps to $90 or higher, the trade is going to reach its maximal profit of $3.75.

  • [By Chris Lange]

    Lowes Companies Inc. (NYSE: LOW) fiscal first-quarter results are scheduled for Wednesday. The consensus earnings estimate is $1.06 per share, on $16.96 billion in revenue. The shares were last seen at $84.59. The consensus price target is $89.27, and the 52-week trading range is $64.87 to $86.25.

  • [By WWW.THESTREET.COM]

    In the battle for your dollars, there have been obvious winners, Cramer said, as Home Depot (HD) trounced Lowe’s (LOW) , and Target (TGT) beat Walmart (WMT) . Meanwhile, both Ross Stores (ROST) and TJX Stores (TJX) saw tremendous growth.

  • [By Ben Levisohn]

    Shares of Home Depot have ticked up 0.1% to $147.32 at 2:55 p.m. today, while Lowe’s (LOW), which my colleague Andrew Bary touted on April 1, has risen 0.4% to $82.26.

better investing: Tetra Technologies, Inc.(TTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from TETRA Technologies, Inc. (NYSE: TTI) and Abraxas Petroleum Corp. (NASDAQ: AXAS).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Wednesday. Top gainers in the sector included TETRA Technologies, Inc. (NYSE: TTI), CARBO Ceramics Inc. (NYSE: CRR), and Atwood Oceanics, Inc. (NYSE: ATW).

better investing: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):